Prolific Machines
Prolific Machines seeks a Technical Project Manager to lead project scoping, planning, and schedule oversight for internal and client-facing initiatives in the biotech optogenetics space. The role involves cross‑functional collaboration with R&D, cell line development, process development, and business teams to ensure clear communication, resource alignment, and successful project delivery.
Headquarters
Emeryville, California, United States
Company Size
11-50 employees
Founded
2020
Prolific Machines is a biotechnology company that pioneers light-controlled biomanufacturing using optogenetics to deliver dynamic, tunable control over protein expression in cell lines. Their platform integrates optogenetic cell line development, plug-and-play illumination hardware, and data-driven process optimization to achieve breakthrough yields — including an industry-record 21g/L titer — and superior quality control for complex biologics such as monoclonal antibodies, bispecifics, Fc fusions, cytokines, and viral vectors. The company partners with biotechs, pharmaceutical companies, and CDMOs through integrated development services, platform licensing, and GMP supply partnerships, all compatible with existing manufacturing infrastructure.
Prolific Machines Announces the Completion of Optogenetic Bioproduction at 200L, Marking the World’s Largest Demonstration of Optogenetics to Date
Apr 17, 2025
Prolific Machines Appoints Former Catalent Chief Scientific Officer to Board of Directors
May 15, 2025
Optogenetics startup Prolific Machines raises $55m series B
Jun 6, 2024
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Prolific Machines.
10% above the average for this role
Prolific Machines Selected to Join FDA's Emerging Technology Program, Advancing the Company’s Novel Biomanufacturing Platform
May 21, 2025